Issue navigation
Volume 18, Issue 8, August 2016
Editorials
Living in a material world: tumor-treating fields at the top of the charts
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1033–1034, https://doi.org/10.1093/neuonc/now138
To diet or not to diet – that is still the question
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1035–1036, https://doi.org/10.1093/neuonc/now131
Longitudinal genomic characterization of brain tumors for identification of therapeutic vulnerabilities
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1037–1039, https://doi.org/10.1093/neuonc/now064
Highlights from the Literature
Highlights from the Literature
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1040–1042, https://doi.org/10.1093/neuonc/now153
Invited Reviews
Updates in the management of brain metastases
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1043–1065, https://doi.org/10.1093/neuonc/now127
Stem cell-based therapies for tumors in the brain: are we there yet?
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1066–1078, https://doi.org/10.1093/neuonc/now096
Basic and Translational Investigations
A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1079–1087, https://doi.org/10.1093/neuonc/now088
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1088–1098, https://doi.org/10.1093/neuonc/now006
Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1099–1108, https://doi.org/10.1093/neuonc/now021
Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1109–1119, https://doi.org/10.1093/neuonc/now022
Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1120–1128, https://doi.org/10.1093/neuonc/now023
CLINICAL INVESTIGATIONS
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1129–1136, https://doi.org/10.1093/neuonc/now102
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1137–1145, https://doi.org/10.1093/neuonc/now002
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1146–1156, https://doi.org/10.1093/neuonc/now009
Pediatric Neuro-Oncology
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1157–1168, https://doi.org/10.1093/neuonc/now026
Neuroimaging
Magnetic resonance analysis of malignant transformation in recurrent glioma
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1169–1179, https://doi.org/10.1093/neuonc/now008
Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1180–1189, https://doi.org/10.1093/neuonc/now036
News and Announcements
Society news
Neuro-Oncology, Volume 18, Issue 8, August 2016, Page 1190, https://doi.org/10.1093/neuonc/now152
